Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Prevention02:59

Cancer Prevention

8.7K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.9K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.9K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

9.2K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

6.3K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.3K
Cancer Vaccines01:30

Cancer Vaccines

1.4K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.4K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

4.4K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
4.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Contamination Characteristics and Source Apportionment of Heavy Metals in Soil around the Agricultural Land in Coal Mining Concentration Areas Based on APCS-MLR and PMF Models].

Huan jing ke xue= Huanjing kexue·2026
Same author

Small-molecule modulators of the androgen receptor N-terminal domain: Advances in medicinal chemistry for prostate cancer.

European journal of medicinal chemistry·2026
Same author

Natural Products Targeting the Androgen Receptor Signaling Pathway: Therapeutic Potential and Mechanisms.

Current issues in molecular biology·2025
Same author

[Pollution Characteristics, Source Analysis, and Health Risk Assessment of Heavy Metals of Soil in a Certain Coal Mining Area of Western Jiangxi Province].

Huan jing ke xue= Huanjing kexue·2025
Same author

Tetracyclic Bis-Piperidine Alkaloids: Structures, Bioinspired Synthesis, Synthesis, and Bioactivities.

Molecules (Basel, Switzerland)·2025
Same author

Mosquito mutations F290V and F331W expressed in acetylcholinesterase of the sand fly Phlebotomus papatasi (Scopoli): biochemical properties and inhibitor sensitivity.

Parasites & vectors·2025

Related Experiment Video

Updated: Apr 18, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.5K

Curcumin-based anti-prostate cancer agents.

Qiao-Hong Chen1

  • 1California State University Fresno, Department of Chemistry, 2555 E. San Ramon Avenue M/S SB 70. qchen@csufresno.edu.

Anti-Cancer Agents in Medicinal Chemistry
|January 17, 2015
PubMed
Summary

Curcumin shows promise for treating prostate cancer, especially castration-resistant forms. Researchers are developing curcumin-based agents to improve its effectiveness and bioavailability for better cancer therapy.

More Related Videos

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.9K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.1K

Related Experiment Videos

Last Updated: Apr 18, 2026

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells
12:55

Assay for Phosphorylation and Microtubule Binding Along with Localization of Tau Protein in Colorectal Cancer Cells

Published on: October 10, 2017

9.5K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.9K
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

14.1K

Area of Science:

  • Oncology
  • Pharmacology
  • Drug Development

Background:

  • Prostate cancer is a leading cause of cancer death in men.
  • Castration-resistant prostate cancer develops resistance to docetaxel, leading to poor outcomes.
  • Dietary curcumin has demonstrated therapeutic potential against prostate cancer in preclinical models.

Purpose of the Study:

  • To review the potential of curcumin in treating prostate cancer.
  • To explore the development of novel curcumin-based agents for enhanced prostate cancer therapy.
  • To examine structure-activity relationships and pharmacokinetic profiles of these agents.

Main Methods:

  • Review of existing literature on curcumin and prostate cancer.
  • Analysis of preclinical studies on curcumin derivatives.
  • Examination of structure-activity relationships and pharmacokinetic data.

Main Results:

  • Curcumin exhibits anticancer properties and a favorable safety profile.
  • Low bioavailability of curcumin necessitates the development of derivatives.
  • Numerous curcumin-based compounds show improved potency and pharmacokinetic profiles.

Conclusions:

  • Curcumin is a promising lead compound for developing new prostate cancer treatments.
  • Curcumin derivatives offer enhanced anticancer potential and improved drug delivery.
  • Further research into curcumin-based agents could lead to improved clinical therapies for prostate cancer.